Our Choices

Aidence

Aidence | Inkef

Mark Jan Harte

Digital Health

2019

Aidence is a company that is bringing the full potential of AI into the hands of medical professionals in medical imaging and disease detection. The company was acquired by RadNet in 2022.

Aito

Aito | Inkef

Rene de Vries

DeepTech

2012

Aito is a user interface innovator that believes “a product is desirable when its interaction is pleasurable.” Aito’s products are based on patented and award-winning Piezo Sensing and Haptics technology.

Ambagon Therapeutics

Ambagon Therapeutics | Inkef

Christian Ottmann, Luc Brunsveld, Michelle Arkin, Scott Clarke

Therapeutics

, Ivan Burkov

2020

Ambagon Therapeutics applies deep knowledge of the 14-3-3 regulatory protein famiy to create “molecular glues” that stabilize 14-3-3:target complexes. These stabilizers amplify native biology to restore or inhibit target function, potentiate target activity, or promote or block target degradation.

Anavo Therapeutics

Anavo Therapeutics | Inkef

Birgit Zech, Gerhard Müller

Therapeutics

Simone Botti,

2020

Anavo Therapeutics is the first biotech company to systematically drug phosphatases, a rich target space previously considered undruggable for decades. With world-leading scientific expertise in phosphatase-driven disease biology and drug discovery, Anavo is working to unlock the full potential of phosphatase-targeted allosteric modulators for oncology applications.

Audion Therapeutics

Audion Therapeutics | Inkef

Rolf Jan Rutten, Helmuth van Es, Albert Edge

Therapeutics

2015

Audion Therapeutics is a private biopharmaceutical company dedicated to the discovery, development and commercialization of drugs and delivery technologies for the treatment of hearing loss.

Baserow

Baserow | Inkef

Bram Wiepjes

Data, Open Source

2022

Baserow is an open-source, no-code database. As an API-first solution, Baserow can be integrated with every tool needed to build a no-code stack. Baserow is on a mission to build the world’s first open-source, all-in-one, no-code toolchain.

Blendle

Blendle | Inkef

Alexander Klöpping, Marten Blankesteijn

Media

Robert Jan Galema,

2014

Blendle is a Dutch online news platform that aggregates articles from a variety of newspapers and magazines and sells them on a pay-per-article basis. The company wants to make the best journalism accessible to anyone, anywhere, anytime. It was acquired by Cafeyn in 2020.

Bloomon

Bloomon | Inkef

Patrick Hurenkamp, Bart Troost and Koen Thijssen

Subscription

2015

Bloomon, is a subscription-based flower delivery service whose goal is to bring bespoke bouquets from grower to consumer in the fastest way possible by cutting out the traditional supply chain. The company was acquired by Bloom & Wild in 2021.

Calypso Biotech

Calypso Biotech | Inkef

Alain Vicari, Yolande Chvatchko

Therapeutics

2018

Calypso Biotech is an immunotherapy biotech company, spin-off from Merck Serono, that discovers and develops monoclonal antibodies for the treatment of immune pathologies with large unmet medical needs. Calypso’s lead program, CALY-002, is a best-in-class therapeutic antibody against interleukin-15.

Cardior

Cardior | Inkef

Thomas Thum, Claudia Ulbrich

Therapeutics

2021

Cardior Pharmaceuticals is pioneering the discovery and development of RNA-based therapeutics designed to prevent, repair and reverse diseases of the heart. Cardior’s therapeutic approach uses distinctive non-coding RNAs as an innovative platform for addressing the root causes of cardiac dysfunctions.

Cashforce

Cashforce | Inkef

Nicolas Christiaen

Fintech

2019

Cashforce helps large enterprises with getting more accurate cash flow forecasts and with managing working capital at a company-wide level while also providing granular insights down to the transaction level by integrating with existing ERP and TMS implementations.

Castor

Castor | Inkef

Derk Arts, Rob Konterman, Sebastiaan Knijnenburg

Digital Health, SaaS

2018

Castor is a medical software development company based in Amsterdam, the Netherlands. Founded in 2011 by Derk Arts, their signature programme is a cloud-based electronic data capture platform which enables researchers to easily capture high-quality, reusable medical data.

ChannelEngine

ChannelEngine | Inkef

Jorrit Steinz

Future of Commerce

2020

ChannelEngine connects seller systems to international marketplaces and sales channels while optimizing sales, minimizing time, and maximizing profit and reach. It offers brands, distributors, and retailers automated order and return systems, an advanced management suite and rich partner ecosystem, to bring their sales to the next level.

Comet Therapeutics

Comet Therapeutics | Inkef

Enej Kuscer

Therapeutics

, Amanda Stenbaek

2017

Comet Therapeutics is focused on developing therapies for rare metabolic disorders. It was acquired by VectivBio in 2021.

Corporis Medical

Corporis Medical | Inkef

John Marugg, Alexander Veenhof

Medical Device

2016

Corporis Medical manufacturers APM, a revolutionary device for bowel cancer surgery. It allows measuring blood flow at the anastomosis in a revolutionary new way during surgery, which can help prevent surgical complications and decrease postoperative deaths, intensive care stay & cost.

Crowdynews

Crowdynews | Inkef

Edwin Kuipers, Jeroen Zanen

Media

2015

Crowdynews is a social media curation platform that gathers and filters relevant social media content and posts it real time next to topical, popular stories. The service provides publishing organizations with new revenue streams and augments content with social media sources such as Twitter, Facebook, YouTube, Instagram and Vimeo.

Draupnir Bio

Draupnir Bio | Inkef

Simon Glerup, Camilla Gustafsen, Peter Seeberger, Andrew Hotchkiss

Therapeutics

2019

Draupnir Bio is a Danish biotechnology company developing small molecule therapeutics to transform the treatment of heart disease, based on proprietary structural insights and the biology of PCSK9, a protein that enables a key step in the control of plasma cholesterol levels.

EclecticIQ

EclecticIQ | Inkef

Joep Gommers, Raymond van der Velde

Cybersecurity

2016

EclecticIQ’s mission is to restore balance in the fight against cyber adversaries. Its flagship product enables operationalization of security information exchange, empowers collaborative analyst workflow and ensures timely integration of cyber threat intelligence detection, prevention and response capabilities.

GeoPhy

GeoPhy | Inkef

Teun van den Dries, Sander Mulders

SaaS, Real Estate

Corné Jansen

2016

GeoPhy provides data-driven valuations and analytics for commercial real estate. Its platform uses supervised machine learning and big data to create insights that help drive acquisition due diligence, portfolio monitoring, and site selection for institutional lenders and investors. The company was acquired by Walker & Dunlop in 2022.

GitLab

GitLab | Inkef

Sid Sijbrandij

DevOps

2016

GitLab is a complete DevOps platform, delivered as a single application, fundamentally changing the way Development, Security, and Ops teams collaborate and build software. GitLab was one of the frontrunners of remote-only distributed teams. The Company was listed on NASDAQ in October 2021.

Happeo

Happeo | Inkef

Perttu Ojansuu, Antero Hanhirova

Future of Work

2020

Happeo is the community-powered employee communications platform that Internal Communications, HR and leaders use to align and engage talent. Happeo serves customers in every continent and is on a mission to change the way companies communicate internally.

InteRNA Technologies

InteRNA Technologies | Inkef

Roel Schaapveld

Therapeutics

2015

InteRNA is a Dutch biotechnology company specializing in the development of RNA therapeutics for the treatment of cancer. The company proprietary technology platform has been developed for discovery and validation of miRNA-based drug candidates for the simultaneous regulation of multiple targets.

Ionctura

Ionctura | Inkef

Cathrine Pickering

Therapeutics

,

2020

iOnctura is a clinical stage biotechnology company developing a pipeline of next generation, differentiated molecules that are at the forefront of pioneering new therapies for the treatment of cancer. The company is developing a series of assets that can uniquely modulate the tumor micro-environment.

Lanthio Pharma

Lanthio Pharma | Inkef

Gert Moll

Therapeutics

2013

Lanthio Pharma is a Dutch biopharmaceutical company committed to developing and commercializing lanthipeptides as innovative drugs for treating medical conditions. It was acquired by MorphoSys in 2015.

Lengoo

Lengoo | Inkef

Christopher Kränzler

SaaS, Translation

2021

Lengoo is a language tech company that supercharges human translators with AI technology. It custom-trains neural machine translation models for its clients using their own data. Lengoo’s language models learn all about the enterprise’s individual way to communicate and produce high-quality machine translation.

NMD Pharma

NMD Pharma | Inkef

Thomas Holm Pedersen

Therapeutics

2018

NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders. Its approach of blocking ClC-1 improves neuromuscular transmission in a way that is potentially applicable to a range of clinical indications and orphan human diseases that have profound unmet medical need.

NPEX

NPEX | Inkef

Mark Van Der Plas

Fintech

2012

NPEX is a fully licensed SME-Exchange in the Netherlands. Unlike traditional exchanges, this auction-based platform enables investors to set a minimum ask price and define the time limits for the bidding process. NPEX focuses on small and medium-sized enterprises looking for growth capital of €500,000 and higher.

NightBalance

NightBalance | Inkef

Eline Vrijland-van Beest, Thijs van Oorschot

Medical Device

2013

NightBalance is a medical device company founded in 2009 and based in Delft, the Netherlands. It developed the Sleep Position Trainer, a proprietary, highly advanced and easy to use device to treat positional obstructive sleep apnea. Nightbalance was acquired by Phillips in 2018.

Onefit

Onefit | Inkef

Serge Barbander, Camille Richardson

Wellness, Subscription

, Laura Waldenstrӧm

2018

Founded in 2012, OneFit offers a market-leading subscription service that allows users to attend any local fitness class or gym for a flat monthly fee. Users have access to the largest network of boutique gyms and studios in the Netherlands. The company was acquired by Urban Sport Club in 2019.

Onward

Onward | Inkef

Grégoire Courtine, Dave Marver

Medical Device

,

2016

ONWARD is creating technologies to improve the movement, independence, and health of people with spinal cord injury. The company is based in Eindhoven, NL and Lausanne, CH and has a growing presence in Boston, US. Two of ONWARD’s technologies have been awarded Breakthrough Device Designation by the FDA. Onward was listed on Euronext in October 2021.

Polarsteps

Polarsteps | Inkef

Maximiliano Neustadt, Koen Droste, Niek Bokkers, Job Harmsen

B2C, Travel

2019

Polarsteps wants to inspire and connect people through travel. It believes that the best way to do that is by creating a place where the entire travel experience is combined within one platform. Its product is used by over 1 million travelers. in 180+ countries.

Precirix

Precirix | Inkef

Tony Lahoutte, Ruth Devenyns

Therapeutics

2022

Precirix is a clinical-stage biotechnology company dedicated to improving the lives of cancer patients by developing novel targeted radiopharmaceuticals using camelid single domain antibody fragments.

ProFibrix

ProFibrix | Inkef

Jaap Koopman

Therapeutics

2011

ProFibrix is a Dutch biotech company that creates, develops, and markets products for the haemostasis and regenerative medicine markets. It was sold to The Medicines Company in 2013.

Provable Labs

Provable Labs | Inkef

Thomer Gil

Fintech

2018

Maximum Liquidity with Minimal Disclosure. Provable labs applies secrecy-preserving, secure multi-party computation technology to build trading platforms that allow participants to express their positions and find liquidity without the risk of price slippage.

Quantum Motion

Quantum Motion | Inkef

John Morton, Simon Benjamin

Deeptech

2020

Quantum Motion is developing silicon spin-based qubit architectures which are compatible with standard CMOS fabrication and so provide easier scaling to thousands and millions of qubits.

QurAlis

QurAlis | Inkef

Kasper Roet

Therapeutics

, Ivan Burkov

2020

QurAlis is developing precision therapeutics for ALS, a terminal disease that causes muscle paralysis through degeneration of the motor system. QurAlis scientist are digging deep into the root causes of the multiple sub-forms of this destructive disease and focus their programs on tackling specific disease-causing mechanisms.

Remote

Remote | Inkef

Job van der Voort, Marcelo Lebre

SaaS, Future of Work

Corné Jansen

2020

Remote is the modern global payroll, tax, HR and compliance solution for distributed teams. Remote enables companies of all sizes to hire anyone, anywhere in the world in minutes. Remote’s mission is to bring remote cultures closer so that people and companies can grow further.

Robin Radar

Robin Radar | Inkef

Siete Hamminga

Security

2012

Robin develops innovative radar systems for detection, tracking and classification of small targets, such as drones or birds.

Salvia BioElectronics

Salvia BioElectronics | Inkef

Hubert Martens, Daniel Schobben, Wim Pollet

Medical Device

Ivan Burkov

2020

Salvia Bioelectronics is developing a medical device for chronic headaches. The company is working on a new neuromodulation approach, to provide relief for patients who suffer from debilitating migraines more than 15 days per month.

Sapiens

Sapiens | Inkef

Sjaak Deckers, Hubert Martens and Michel Decré

Medical Device

2013

Sapiens is a Dutch developer of deep brain stimulation (DBS) technologies, an advanced treatment that targets degenerative or functional brain disorders such as Parkinson’s disease and dystonia. The company was acquired by Medtronic in 2014.

Scenic Biotech

Scenic Biotech | Inkef

Thijn Brummelkapmp, Sebastian Nijman

Therapeutics

2017

Scenic Biotech BV is a spinout company of the Netherlands Cancer Institute (NKI) and Oxford University, based in Amsterdam, The Netherlands. It is Scenic Biotech’s mission to harness genetic modifiers to combat disease. The company was founded by Prof Thijn Brummelkamp and Prof Sebastian Nijman.

Sentinels

Sentinels | Inkef

Joost van Houten

SaaS, KYC/AML

,

2021

Sentinels is an intelligent transaction monitoring solution dedicated to data-driven compliance for the financial industry. With a team of exceptionally talented AI/ML engineers, Sentinels’ pragmatic-AI approach has a proven track record in improving compliance outcomes. The company was acquired by Fenergo in 2022.

Shapeways

Shapeways | Inkef

Peter Weijmarshausen, Marleen Vogelaarm Robert Schouwenburg, Gregory Kress

Marketplace, Manufacturing

Robert Jan Galema,

2015

Shapeways is the world’s leading 3D printing service and marketplace, empowering designers to bring amazing products to life. By giving anyone the ability to quickly and affordably turn ideas from digital designs into real products, Shapeways is fundamentally changing how products are made and by whom. The Company was listed on NYSE in September 2021.

Silverflow

Silverflow | Inkef

Paul Buying, Robert Kraal, Anne Willem de Vries

Fintech

, Corné Jansen

2020

Silverflow is a payments technology company, founded by online payments industry veterans, with the mission to accelerate technological innovation in the complex payments value chain. Silverflow’s cloud-based platform provides a state-of-the-art upgrade and direct access to the card networks for payment services providers, merchants and acquirers.

TargED Biopharmaceuticals

TargED Biopharmaceuticals | Inkef

Marc van Moorsel, Steven de Maat, Coen Maas, Kristof Vercuysse

Therapeutics

2022

TargED Biopharmaceuticals B.V. is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis. Their technology using small antibodies to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis. The lead compound is currently under development for thrombotic thrombocytopenic purpura and Acute Ischemic Stroke.

Urban Sports Club

Urban Sports Club | Inkef

Moritz Kreppel, Benjamn Roth

Wellness, Subscription

2019

Urban Sports Club offers a flexible flat-rate sports membership. Club members can choose from 50+ activities – ranging from classic gym workout, swimming, yoga, or bouldering, to team sports and lots more – and more than 7,000 partner venues across Europe.

VarmX

VarmX | Inkef

Pieter Reitsma, Jan Ohrstrom

Therapeutics

,

2020

VarmX is a spin out of Leiden University Medical Center. Its lead program is an innovative antidote for life-threatening bleeding in the ever growing number of patients under Factor Xa anticoagulant treatment. VarmX is also developing new technologies to address risks from new classes of anticoagulants.

ViCentra

ViCentra | Inkef

Frans Cromme

Medical Device

2013

ViCentra has developed an insulin pump for diabetes patients. The company aims to create a user-friendly device designed to provide diabetes patients with greater freedom in their day-to-day lives.

Wercker

Wercker | Inkef

Micha “Mies” Hernandez van Leuffen

SaaS, DevOps

2016

Wercker is a continuous delivery platform focusing on changing the way developers build and deploy their applications. Its platform was built in order to make developers’ lives easier and enabling them to move fast and make things. The company was acquired by Oracle in 2017.

Withlocals

Withlocals | Inkef

Marijn Maas, Willem Maas, Bas Visser, Ronald Crooy, Matthijs Keij

Marketplace, Travel

2017

Withlocals is an online marketplace for travelers and locals to connect. The platform lets locals create personal and unique travel experiences for travelers, earn their fair share by doing what they love, and gives travelers authentic experiences and stories to share with their friends and families.

Jobs

If you share our passion for backing the best entrepreneurs and building lasting, legendary companies – we’d love to work with you.

We have no vacancies at the moment, please check in later